Xiaobing Niu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaobing Niu has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Fei Mao
2 shared publications- Weijing Tao
Nuclear Medicine
2 shared publications Baotai Liang
Department of Urology, Zhongda Hospital, Southeast University, Nanjing, China
1 shared publicationChaobo Jin
1 shared publicationDafei Weng
Department of Urology, Yixing People’s Hospital, Yixing, China
1 shared publication- Dongfang Jiang
The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, China
1 shared publication
Latest Publications
- Open Access
- 2 February 2026
- Published by Wolters Kluwer Health in Current Urology
- Vol. 20 (3) , 180-184
Intermediate-term follow-up and analysis of related factors associated with urinary incontinence and overactive bladder after laparoscopic radical prostatectomy—A multicenter cross-sectional study in China
Purpose: The aim of this study was to evaluate the incidence of urinary incontinence (UI) and overactive bladder (OAB) in prostate cancer patients 12 months after laparoscopic radical prostatectomy (LRP), through a multicenter follow-up. Additionally, the study sought to analyze the association between potential risk factors and the occurrence of these complications. Methods: This retrospective study included 382 patients who underwent LRP across 9 institutions in Jiangsu Province, China, between January 2019 and March 2020. Clinical data, including the Overactive Bladder Symptom Score, the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form, magnetic resonance imaging findings, and the number of pads used, were collected 12 months postoperatively to assess the incidence of UI and OAB. Univariate and multivariate analyses were conducted to identify factors associated with UI and bladder overactivity at the 12-month follow-up. Results: Among the 382 patients included in the analysis, 135 (35.3%) patients remained affected by UI 12 months after LRP. Multivariate statistical analysis identified membranous urethral length (MUL), body mass index (BMI), and age as significant predictors of UI at the 12 - month postoperative mark. Additionally, 139 (36.4%) patients reported the presence of overactive bladder (OAB) 12 months post - operation. UI and OAB were found to be risk factors for each other. Conclusions: In our multicenter retrospective study, the prevalence of UI and OAB 12 months after LRP was significantly higher than previously reported in the literature. Age, BMI, and MUL were found to be associated with postoperative UI. Notably, preoperative MUL served as a protective factor against UI at 12 months post-surgery, while UI and OAB were identified as mutual risk factors. These findings underscore the importance of preventing post-prostatectomy UI to mitigate or avoid the occurrence of postoperative OAB. It should be noted that the loss-to-follow-up rate in this study was 39.7%, which may limit the interpretation and generalizability of the results.
- 2 February 2026
- Published by Wolters Kluwer Health in Current Urology
- Vol. 20 (3) , 180-184
Open AccessIntermediate-term follow-up and analysis of related factors associated with urinary incontinence and overactive bladder after laparoscopic radical prostatectomy—A multicenter cross-sectional study in China
Purpose: The aim of this study was to evaluate the incidence of urinary incontinence (UI) and overactive bladder (OAB) in prostate cancer patients 12 months after laparoscopic radical prostatectomy (LRP), through a multicenter follow-up. Additionally, the study sought to analyze the association between potential risk factors and the occurrence of these complications. Methods: This retrospective study included 382 patients who underwent LRP across 9 institutions in Jiangsu Province, China, between January 2019 and March 2020. Clinical data, including the Overactive Bladder Symptom Score, the International Consultation on Incontinence Questionnaire–Urinary Incontinence Short Form, magnetic resonance imaging findings, and the number of pads used, were collected 12 months postoperatively to assess the incidence of UI and OAB. Univariate and multivariate analyses were conducted to identify factors associated with UI and bladder overactivity at the 12-month follow-up. Results: Among the 382 patients included in the analysis, 135 (35.3%) patients remained affected by UI 12 months after LRP. Multivariate statistical analysis identified membranous urethral length (MUL), body mass index (BMI), and age as significant predictors of UI at the 12 - month postoperative mark. Additionally, 139 (36.4%) patients reported the presence of overactive bladder (OAB) 12 months post - operation. UI and OAB were found to be risk factors for each other. Conclusions: In our multicenter retrospective study, the prevalence of UI and OAB 12 months after LRP was significantly higher than previously reported in the literature. Age, BMI, and MUL were found to be associated with postoperative UI. Notably, preoperative MUL served as a protective factor against UI at 12 months post-surgery, while UI and OAB were identified as mutual risk factors. These findings underscore the importance of preventing post-prostatectomy UI to mitigate or avoid the occurrence of postoperative OAB. It should be noted that the loss-to-follow-up rate in this study was 39.7%, which may limit the interpretation and generalizability of the results.
- Open Access
- 1 February 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (2) , 172
PSMA-RADS 2.0: clinical validation and technical considerations for prostate-specific membrane antigen positron emission tomography/computed tomography image interpretation
Background: The updated diagnostic framework prostate-specific membrane antigen Reporting and Data System 2.0 (PSMA-RADS 2.0) has been introduced as a standardized scoring system for PSMA positron emission tomography/computed tomography (PET/CT) structured reporting to enhance the accuracy and clinical utility of prostate cancer (PCa) lesion interpretation. This study aims to evaluate the reliability and identify potential limitations of PSMA-RADS 2.0 in clinical applications. Methods: We conducted a comparative analysis between PSMA-RADS versions 1.0 and 2.0, followed by prospective evaluation of 109 lesions using PSMA-RADS 2.0 criteria. Inter- and intra-reader consistencies were analyzed statistically to evaluate the reliability and practicality of the scoring system. In the context of two independent readings, the inter-reader consistency between experienced readers (ERs) and inexperienced readers (IRs) was evaluated using the intra-class correlation coefficient (ICC). Results: Compared to version 1.0, PSMA-RADS 2.0 simplified primary PSMA-RADS-1 classification for Category I lesions and introduced PSMA-RADS-5T for post-treatment assessment. Inter-reader correlation coefficients values demonstrated excellent consistency (ERs: 0.964–0.969; IRs: 0.929–0.932). Intra-reader correlation coefficients ranged from 0.920 to 0.985 across all readers. However, challenges persisted in lymph node interpretation (ICC: 0.797–0.823) and post-treatment classification. Conclusions: PSMA-RADS 2.0 provides a reliable framework for PSMA PET/CT interpretation, even for IRs. Further refinement is needed for post-treatment categorization and lymph node differentiation. The proposed PSMA-RADS-5T sub-classification complete remission/partial remission/stability disease/progression disease (CR/PR/SD/PD) may enhance clinical utility for treatment monitoring.
- 1 February 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (2) , 172
Open AccessPSMA-RADS 2.0: clinical validation and technical considerations for prostate-specific membrane antigen positron emission tomography/computed tomography image interpretation
Background: The updated diagnostic framework prostate-specific membrane antigen Reporting and Data System 2.0 (PSMA-RADS 2.0) has been introduced as a standardized scoring system for PSMA positron emission tomography/computed tomography (PET/CT) structured reporting to enhance the accuracy and clinical utility of prostate cancer (PCa) lesion interpretation. This study aims to evaluate the reliability and identify potential limitations of PSMA-RADS 2.0 in clinical applications. Methods: We conducted a comparative analysis between PSMA-RADS versions 1.0 and 2.0, followed by prospective evaluation of 109 lesions using PSMA-RADS 2.0 criteria. Inter- and intra-reader consistencies were analyzed statistically to evaluate the reliability and practicality of the scoring system. In the context of two independent readings, the inter-reader consistency between experienced readers (ERs) and inexperienced readers (IRs) was evaluated using the intra-class correlation coefficient (ICC). Results: Compared to version 1.0, PSMA-RADS 2.0 simplified primary PSMA-RADS-1 classification for Category I lesions and introduced PSMA-RADS-5T for post-treatment assessment. Inter-reader correlation coefficients values demonstrated excellent consistency (ERs: 0.964–0.969; IRs: 0.929–0.932). Intra-reader correlation coefficients ranged from 0.920 to 0.985 across all readers. However, challenges persisted in lymph node interpretation (ICC: 0.797–0.823) and post-treatment classification. Conclusions: PSMA-RADS 2.0 provides a reliable framework for PSMA PET/CT interpretation, even for IRs. Further refinement is needed for post-treatment categorization and lymph node differentiation. The proposed PSMA-RADS-5T sub-classification complete remission/partial remission/stability disease/progression disease (CR/PR/SD/PD) may enhance clinical utility for treatment monitoring.
- Open Access
- 22 September 2025
- Published by Spandidos Publications in Biomedical Reports
- Vol. 23 (5) , 1-9
Inflammation-immune‑nutrition biomarkers and PSA variability: A population‑based study on the clinical potential of the CALLY index
Prostate cancer (PCa) is the second leading cause of cancer‑associated mortalities worldwide. Prostate‑specific antigen (PSA) testing is pivotal for screening for PCa, despite its limited specificity due to confounding factors such as inflammation and nutritional status. The present study investigated the association between the C‑reactive protein (CRP)‑albumin‑lymphocyte (CALLY) index and PSA levels in a population without PCa. Using data from 5,320 men aged ≥40 years from the 2003‑2010 national health and nutrition examination survey cycles, weighted multivariate linear regression and restricted cubic spline analyses were conducted. The findings revealed a significant inverse linear association: For each unit increase in the CALLY index, the PSA levels decreased by 0.09 ng/ml (β coefficient, ‑0.09; 95% confidence interval, ‑0.16 to ‑0.02). This association persisted across individuals with different ages, smoking habits and comorbidity subgroups. By integrating markers of systemic inflammation (such as the CRP levels), nutritional status (such as the albumin levels) and adaptive immunity (such as the lymphocyte counts), the CALLY index may refine the interpretation of the PSA levels and reduce the number of PCa false positive results, which occur due to subclinical inflammation. The present cross‑sectional study highlighted that the CALLY index, as an adjunct biomarker, may have increased the accuracy of the screening for PCa. However, due to the cross‑sectional design of the present study, causal associations cannot be established, and clinical applicability should be interpreted with caution. Therefore, further longitudinal and experimental studies are needed to elucidate the causal pathways and underlying mechanisms that link the CALLY index to the PSA levels.
- 22 September 2025
- Published by Spandidos Publications in Biomedical Reports
- Vol. 23 (5) , 1-9
Open AccessInflammation-immune‑nutrition biomarkers and PSA variability: A population‑based study on the clinical potential of the CALLY index
Prostate cancer (PCa) is the second leading cause of cancer‑associated mortalities worldwide. Prostate‑specific antigen (PSA) testing is pivotal for screening for PCa, despite its limited specificity due to confounding factors such as inflammation and nutritional status. The present study investigated the association between the C‑reactive protein (CRP)‑albumin‑lymphocyte (CALLY) index and PSA levels in a population without PCa. Using data from 5,320 men aged ≥40 years from the 2003‑2010 national health and nutrition examination survey cycles, weighted multivariate linear regression and restricted cubic spline analyses were conducted. The findings revealed a significant inverse linear association: For each unit increase in the CALLY index, the PSA levels decreased by 0.09 ng/ml (β coefficient, ‑0.09; 95% confidence interval, ‑0.16 to ‑0.02). This association persisted across individuals with different ages, smoking habits and comorbidity subgroups. By integrating markers of systemic inflammation (such as the CRP levels), nutritional status (such as the albumin levels) and adaptive immunity (such as the lymphocyte counts), the CALLY index may refine the interpretation of the PSA levels and reduce the number of PCa false positive results, which occur due to subclinical inflammation. The present cross‑sectional study highlighted that the CALLY index, as an adjunct biomarker, may have increased the accuracy of the screening for PCa. However, due to the cross‑sectional design of the present study, causal associations cannot be established, and clinical applicability should be interpreted with caution. Therefore, further longitudinal and experimental studies are needed to elucidate the causal pathways and underlying mechanisms that link the CALLY index to the PSA levels.
- Open Access
- 1 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
Biochemical recurrence (BCR) of prostate cancer (PCa) negatively impacts patients’ post-surgery quality of life, and the traditional predictive models have shown limited accuracy. This study develops an AI-based prognostic model using deep learning that incorporates androgen receptor (AR) regional features from whole-slide images (WSIs). Data from 545 patients across two centres are used for training and validation. The model showed strong performances, with high accuracy in identifying regions with high AR expression and BCR prediction. This AI model may help identify high-risk patients, aiding in better treatment strategies, particularly in underdeveloped areas.
- 1 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessAI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
Biochemical recurrence (BCR) of prostate cancer (PCa) negatively impacts patients’ post-surgery quality of life, and the traditional predictive models have shown limited accuracy. This study develops an AI-based prognostic model using deep learning that incorporates androgen receptor (AR) regional features from whole-slide images (WSIs). Data from 545 patients across two centres are used for training and validation. The model showed strong performances, with high accuracy in identifying regions with high AR expression and BCR prediction. This AI model may help identify high-risk patients, aiding in better treatment strategies, particularly in underdeveloped areas.
- Open Access
- 26 March 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (6) , 530-531
Solitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT
Solitary fibrous tumors are fibroblast tumors that occur mainly in the peritoneum, extremities, and pleura. Here, we report the MRI, FDG PET/CT, and FAPI PET/CT findings of a rare prostate solitary fibrous tumor. A 57-year-old man was pathologically diagnosed with a solitary fibrous tumor. To detect any systemic metastases or other primary lesions, the patient underwent FDG PET/CT and FAPI PET/CT examination sequentially. Mild FDG uptake was observed in the primary prostatic lesion, but there was a significant uptake of FAPI in the prostate. This case highlighted that FAPI PET/CT may outperform FDG PET/CT in identifying solitary fibrous tumors.
- 26 March 2023
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 48 (6) , 530-531
Open AccessSolitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT
Solitary fibrous tumors are fibroblast tumors that occur mainly in the peritoneum, extremities, and pleura. Here, we report the MRI, FDG PET/CT, and FAPI PET/CT findings of a rare prostate solitary fibrous tumor. A 57-year-old man was pathologically diagnosed with a solitary fibrous tumor. To detect any systemic metastases or other primary lesions, the patient underwent FDG PET/CT and FAPI PET/CT examination sequentially. Mild FDG uptake was observed in the primary prostatic lesion, but there was a significant uptake of FAPI in the prostate. This case highlighted that FAPI PET/CT may outperform FDG PET/CT in identifying solitary fibrous tumors.